融捷健康
(300247)
| 流通市值：21.61亿 | | | 总市值：21.63亿 |
| 流通股本：8.03亿 | | | 总股本：8.04亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 176,333,541.57 | 529,447,502.52 | 374,171,590.65 | 271,201,740.22 |
| 营业收入 | 176,333,541.57 | 529,447,502.52 | 374,171,590.65 | 271,201,740.22 |
| 二、营业总成本 | 144,828,814.76 | 481,036,285.01 | 334,013,481.01 | 236,947,135.92 |
| 营业成本 | 121,649,522.98 | 355,471,236.23 | 253,494,014.52 | 181,667,862.83 |
| 税金及附加 | 1,814,972.25 | 4,824,040.63 | 3,178,208.08 | 2,442,660.21 |
| 销售费用 | 11,285,311.89 | 61,544,156.34 | 33,889,746.12 | 23,563,927.81 |
| 管理费用 | 11,363,936.82 | 58,011,082.15 | 46,410,869.37 | 33,339,065.73 |
| 研发费用 | 2,369,330.52 | 9,057,948.76 | 6,547,019.26 | 3,917,368.56 |
| 财务费用 | -3,654,259.7 | -7,872,179.1 | -9,506,376.34 | -7,983,749.22 |
| 其中:利息收入 | 2,968,694.78 | - | - | 3,283,346.76 |
| 加:公允价值变动收益 | 3,987,929.1 | 13,317,102.51 | 10,985,212.51 | 7,232,891.99 |
| 加:投资收益 | 230,549.32 | 3,961,282.12 | 1,874,302.68 | 697,347.1 |
| 资产处置收益 | -5,382.58 | -497,917.34 | -408,384.39 | -116,822.39 |
| 资产减值损失(新) | 1,080.31 | -7,558,965.39 | -4,514,337.52 | -2,846,504.93 |
| 信用减值损失(新) | 407,009.48 | 526,816.45 | 1,004,965.12 | 916,926.12 |
| 其他收益 | 654,674.49 | 1,264,169.64 | 583,629.64 | 463,229.64 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 36,780,586.93 | 59,423,705.5 | 49,683,497.68 | 40,601,671.83 |
| 加:营业外收入 | 3,568.23 | 1,099,859.02 | 592,888.8 | 22,684.47 |
| 减:营业外支出 | 28,182.94 | 764,700.45 | 176,913.17 | 79,605.76 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 36,755,972.22 | 59,758,864.07 | 50,099,473.31 | 40,544,750.54 |
| 减:所得税费用 | 8,535,988.1 | 17,840,052.72 | 11,407,540.69 | 8,494,963.82 |
| 六、净利润 | 28,219,984.12 | 41,918,811.35 | 38,691,932.62 | 32,049,786.72 |
| 持续经营净利润 | 28,219,984.12 | 41,918,811.35 | 38,691,932.62 | 32,049,786.72 |
| 归属于母公司股东的净利润 | 20,825,834.91 | 26,582,643.81 | 25,687,984.91 | 21,039,872.14 |
| 少数股东损益 | 7,394,149.21 | 15,336,167.54 | 13,003,947.71 | 11,009,914.58 |
| (一)基本每股收益 | 0.03 | 0.03 | 0.03 | 0.03 |
| (二)稀释每股收益 | 0.03 | 0.03 | 0.03 | 0.03 |
| 八、其他综合收益 | -2,715,712.45 | 2,014,882.87 | 4,834,453.28 | 6,315,277.16 |
| 归属于母公司股东的其他综合收益 | -1,765,213.1 | 1,309,673.87 | 2,624,106.28 | 4,104,930.15 |
| 九、综合收益总额 | 25,504,271.67 | 43,933,694.22 | 43,526,385.9 | 38,365,063.88 |
| 归属于母公司股东的综合收益总额 | 19,060,621.81 | 27,892,317.68 | 28,312,091.19 | 25,144,802.29 |
| 归属于少数股东的综合收益总额 | 6,443,649.86 | 16,041,376.54 | 15,214,294.71 | 13,220,261.59 |
| 公告日期 | 2024-04-25 | 2024-04-24 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |